A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

EK1 is a broad-spectrum human coronavirus fusion inhibitor for combating infection of current and emerging coronaviruses. Continuously emerging highly pathogenic human coronaviruses (HCoVs) remain a major threat to human health, as illustrated in past SARS-CoV and MERS-CoV outbreaks. The development of a drug with broad-spectrum HCoV inhibitory activity would address this urgent unmet medical need. Although previous studies have suggested that the HR1 of HCoV spike (S) protein is an important target site for inhibition against specific HCoVs, whether this conserved region could serve as a target for the development of broad-spectrum pan-CoV inhibitor remains controversial. Here, we found that peptide OC43-HR2P, derived from the HR2 domain of HCoV-OC43, exhibited broad fusion inhibitory activity against multiple HCoVs. EK1, the optimized form of OC43-HR2P, showed substantially improved pan-CoV fusion inhibitory activity and pharmaceutical properties. Crystal structures indicated that EK1 can form a stable six-helix bundle structure with both short α-HCoV and long β-HCoV HR1s, further supporting the role of HR1 region as a viable pan-CoV target site.

[1]  Shibo Jiang,et al.  HIV gp41 C-terminal Heptad Repeat Contains Multifunctional Domains , 2007, Journal of Biological Chemistry.

[2]  J. White,et al.  Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex. , 2000, Biochemistry.

[3]  Benhur Lee,et al.  A catalytically and genetically optimized β-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics , 2009, Virology Journal.

[4]  Y. Guan,et al.  Human Coronavirus NL63 Infection and Other Coronavirus Infections in Children Hospitalized with Acute Respiratory Disease in Hong Kong, China , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Lu Lu,et al.  Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein , 2014, Virus Research.

[6]  Shinji Watanabe,et al.  Functional Importance of the Coiled-Coil of the Ebola Virus Glycoprotein , 2000, Journal of Virology.

[7]  K. Shirato,et al.  Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry , 2016, Journal of Virology.

[8]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[9]  G. Salitra,et al.  Nested fullerene-like structures , 1993, Nature.

[10]  I. Wilson,et al.  Crystal structure of the post‐fusion core of the Human coronavirus 229E spike protein at 1.86 Å resolution , 2018, Acta crystallographica. Section D, Structural biology.

[11]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[12]  Xiaodong Cheng,et al.  Blocking of Exchange Proteins Directly Activated by cAMP Leads to Reduced Replication of Middle East Respiratory Syndrome Coronavirus , 2014, Journal of Virology.

[13]  Y H Chen,et al.  Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. , 1974, Biochemistry.

[14]  R. Baric,et al.  Two Mutations Were Critical for Bat-to-Human Transmission of Middle East Respiratory Syndrome Coronavirus , 2015, Journal of Virology.

[15]  T. Jacques,et al.  Human Coronavirus OC43 Associated with Fatal Encephalitis. , 2016, The New England journal of medicine.

[16]  J. Maurer.  Human Coronavirus and Acute Respiratory Illness in Older Adults with Chronic Obstructive Pulmonary Disease , 2010 .

[17]  P. Brossart,et al.  Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN‐alpha in a patient with newly diagnosed ALL , 2016, European journal of haematology.

[18]  Shibo Jiang,et al.  HIV-1 inhibition by a peptide , 1993, Nature.

[19]  Shibo Jiang,et al.  De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery , 2018, Journal of medicinal chemistry.

[20]  Shibo Jiang,et al.  Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors , 2018, Journal of medicinal chemistry.

[21]  M. Semret,et al.  Severity and Outcome Associated With Human Coronavirus OC43 Infections Among Children , 2013, The Pediatric infectious disease journal.

[22]  Christian Drosten,et al.  Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like Protease , 2011, Journal of Virology.

[23]  Y. Takebe,et al.  Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia , 2016, Virology Journal.

[24]  Lu Lu,et al.  Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor , 2014, Nature Communications.

[25]  K. Shirato,et al.  Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry , 2017, Virology.

[26]  K. Nichol,et al.  Human Coronavirus and Acute Respiratory Illness in Older Adults with Chronic Obstructive Pulmonary Disease , 2009, The Journal of infectious diseases.

[27]  Randy J. Read,et al.  Phenix - a comprehensive python-based system for macromolecular structure solution , 2012 .

[28]  S. Harrison,et al.  Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor , 2005, Science.

[29]  J. Epstein,et al.  Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor , 2013, Nature.

[30]  P. Woo,et al.  Molecular Epidemiology of Human Coronavirus OC43 Reveals Evolution of Different Genotypes over Time and Recent Emergence of a Novel Genotype due to Natural Recombination , 2011, Journal of Virology.

[31]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[32]  Kok-Gan Chan,et al.  Identification and evolutionary dynamics of two novel human coronavirus OC43 genotypes associated with acute respiratory infections: phylogenetic, spatiotemporal and transmission network analyses , 2017, Emerging Microbes &Infections.

[33]  W. Greene,et al.  A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes , 2002, Nature Biotechnology.

[34]  R. L. Baldwin,et al.  Helix stabilization by Glu-...Lys+ salt bridges in short peptides of de novo design. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  W. Greene,et al.  Studies of Ebola Virus Glycoprotein-Mediated Entry and Fusion by Using Pseudotyped Human Immunodeficiency Virus Type 1 Virions: Involvement of Cytoskeletal Proteins and Enhancement by Tumor Necrosis Factor Alpha , 2005, Journal of Virology.

[36]  V. Gulani,et al.  MR Molecular Imaging of Prostate Cancer with a Peptide-Targeted Contrast Agent in a Mouse Orthotopic Prostate Cancer Model , 2011, Pharmaceutical Research.

[37]  Nathan A. Baker,et al.  PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations , 2004, Nucleic Acids Res..

[38]  G. Gao,et al.  Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond , 2015, Trends in Microbiology.

[39]  A. Debnath,et al.  Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors , 2004, The Lancet.

[40]  T. Matthews,et al.  Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Lu Lu,et al.  Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection , 2015, The Journal of infectious diseases.

[42]  Makoto Takeda,et al.  Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2 , 2010, Journal of Virology.

[43]  C. Broder,et al.  Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein , 2005, Virology Journal.

[44]  R. Liddington,et al.  Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness , 2014, Journal of Virology.

[45]  B. Berkhout,et al.  Core structure of S2 from the human coronavirus NL63 spike glycoprotein. , 2006, Biochemistry.

[46]  J. Lepault,et al.  Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Kwok-Hung Chan,et al.  Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus , 2012, Journal of Virology.

[48]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[49]  G. Gao,et al.  Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses , 2016, Trends in Microbiology.

[50]  Marco Biasini,et al.  SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information , 2014, Nucleic Acids Res..

[51]  C. Morimoto,et al.  Bilateral Entry and Release of Middle East Respiratory Syndrome Coronavirus Induces Profound Apoptosis of Human Bronchial Epithelial Cells , 2013, Journal of Virology.

[52]  Y. Guan,et al.  Human Coronavirus NL63 Infection and Other Coronavirus Infections in Children Hospitalized with Acute Respiratory Disease in Hong Kong, China , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  K. Landfester,et al.  Pharmacokinetics on a microscale: visualizing Cy5-labeled oligonucleotide release from poly(n-butylcyanoacrylate) nanocapsules in cells , 2014, International journal of nanomedicine.

[54]  D. Dimitrov,et al.  Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies , 2014, Journal of Virology.

[55]  Ting-Chao Chou,et al.  Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.

[56]  M. Matsuoka,et al.  Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells. , 2002, Angewandte Chemie.

[57]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[58]  Lisa E. Gralinski,et al.  SARS-like WIV1-CoV poised for human emergence , 2016, Proceedings of the National Academy of Sciences.

[59]  P. S. Kim,et al.  A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein. , 1997, Journal of biomolecular structure & dynamics.

[60]  K. Pyrć,et al.  Biopolymeric nano/microspheres for selective and reversible adsorption of coronaviruses , 2017, Materials Science and Engineering: C.

[61]  R. Lamb,et al.  Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion , 2001, The EMBO journal.

[62]  H. Aydin,et al.  Influence of hydrophobic and electrostatic residues on SARS-coronavirus S2 protein stability: Insights into mechanisms of general viral fusion and inhibitor design , 2014, Protein science : a publication of the Protein Society.

[63]  Robert J. Fischer,et al.  Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape , 2018, Journal of Virology.

[64]  Fang Li,et al.  Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies , 2014, Journal of Virology.

[65]  K. Yuen,et al.  A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses , 2017, Nature Communications.

[66]  M. Desforges,et al.  Novel Treatment with Neuroprotective and Antiviral Properties against a Neuroinvasive Human Respiratory Virus , 2013, Journal of Virology.

[67]  W. Greene,et al.  HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion. , 2004, Virology.

[68]  A. Simon,et al.  Acute life threatening event (ALTE) in an infant with human coronavirus HCoV‐229E infection , 2007, Pediatric pulmonology.

[69]  P. Talbot,et al.  Vacuolating encephalitis in mice infected by human coronavirus OC43 , 2003, Virology.

[70]  Lisa E. Gralinski,et al.  A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence , 2015, Nature Medicine.

[71]  S. Perlman,et al.  The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases , 2017, PLoS pathogens.

[72]  Yufei Wang,et al.  Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants , 2016, Journal of Virology.

[73]  Shibo Jiang,et al.  Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV-1 fusion inhibitors , 2003, Peptides.

[74]  P. Woo,et al.  Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5 , 2012, Emerging Microbes & Infections.

[75]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[76]  Lu Lu,et al.  Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines , 2012, Emerging Microbes & Infections.

[77]  Young Woo Park,et al.  Type II transmembrane serine proteases in cancer and viral infections. , 2009, Trends in molecular medicine.

[78]  B. Bosch,et al.  The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex , 2003, Journal of Virology.